Lawmakers in both the House and Senate are introducing bills targeting China’s largest genomics company, BGI, to block Beijing from using U.S. tax dollars to develop bioweapons that could target Americans. If the bills go through, medical providers funded by federal money won’t be able to use BGI products.
US Congress Pushes Bill to Ban Chinese Biotech Firm
By NTD Newsroom